Registry Search

ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER

Other drugs that lower heart rate or blood pressure can have additive effects Can cause profound hypotension and bradycardia.

ESOMEPRAZOLE MAGNESIUM

Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.

ESOMEPRAZOLE SODIUM

Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.

ESOMEPRAZOLE STRONTIUM

Can reduce absorption of drugs requiring gastric pH for absorption (eg ketoconazole) May increase risk of Clostridium difficile-associated diarrhea and bone fractures with long-term use.

ESTARYLLA

Comprehensive clinical and safety monograph for ESTARYLLA (ESTARYLLA).

ESTAZOLAM

CNS depressants including alcohol and opioids increase sedation risk Abrupt discontinuation can cause withdrawal symptoms.

ESTERIFIED ESTROGENS

Comprehensive clinical and safety monograph for ESTERIFIED ESTROGENS (ESTERIFIED ESTROGENS).

ESTINYL

Comprehensive clinical and safety monograph for ESTINYL (ESTINYL).

ESTRACE

Comprehensive clinical and safety monograph for ESTRACE (ESTRACE).

ESTRADERM

Comprehensive clinical and safety monograph for ESTRADERM (ESTRADERM).

ESTRADIOL

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ESTRADIOL AND NORETHINDRONE ACETATE

CYP3A4 inducers can decrease efficacy Can cause thromboembolic disorders.

ESTRADIOL AND NORGESTIMATE

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ESTRADIOL AND PROGESTERONE

CYP3A4 inducers can decrease efficacy Can cause thromboembolic disorders.

ESTRADIOL CYPIONATE

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ESTRADIOL VALERATE

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ESTRADIOL VALERATE AND DIENOGEST

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ESTRADIOL VALERATE; ESTRADIOL VALERATE; DIENOGEST

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ESTRADURIN

Comprehensive clinical and safety monograph for ESTRADURIN (ESTRADURIN).

ESTRAGUARD

Comprehensive clinical and safety monograph for ESTRAGUARD (ESTRAGUARD).

ESTRASORB

Comprehensive clinical and safety monograph for ESTRASORB (ESTRASORB).

ESTRATAB

Comprehensive clinical and safety monograph for ESTRATAB (ESTRATAB).

ESTRING

Comprehensive clinical and safety monograph for ESTRING (ESTRING).

ESTROGEL

Comprehensive clinical and safety monograph for ESTROGEL (ESTROGEL).

ESTROGENIC SUBSTANCE

Comprehensive clinical and safety monograph for ESTROGENIC SUBSTANCE (ESTROGENIC SUBSTANCE).

ESTRONE

Comprehensive clinical and safety monograph for ESTRONE (ESTRONE).

ESTROPIPATE

Comprehensive clinical and safety monograph for ESTROPIPATE (ESTROPIPATE).

ESTROSTEP 21

Comprehensive clinical and safety monograph for ESTROSTEP 21 (ESTROSTEP 21).

ESTROSTEP FE

Comprehensive clinical and safety monograph for ESTROSTEP FE (ESTROSTEP FE).

ESTROVIS

Comprehensive clinical and safety monograph for ESTROVIS (ESTROVIS).

ESZOPICLONE

CNS depressants including alcohol increase sedation risk May cause complex sleep behaviors like sleep-driving.

ETHACRYNATE SODIUM

Comprehensive clinical and safety monograph for ETHACRYNATE SODIUM (ETHACRYNATE SODIUM).

ETHACRYNIC ACID

Comprehensive clinical and safety monograph for ETHACRYNIC ACID (ETHACRYNIC ACID).

ETHAMBUTOL HYDROCHLORIDE

Aluminum hydroxide may decrease absorption Can cause optic neuritis leading to decreased visual acuity and color blindness.

ETHAMIDE

Comprehensive clinical and safety monograph for ETHAMIDE (ETHAMIDE).

ETHAMOLIN

Comprehensive clinical and safety monograph for ETHAMOLIN (ETHAMOLIN).

ETHCHLORVYNOL

Comprehensive clinical and safety monograph for ETHCHLORVYNOL (ETHCHLORVYNOL).

ETHINYL ESTRADIOL AND LEVONORGESTREL

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ETHINYL ESTRADIOL AND NORELGESTROMIN

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ETHINYL ESTRADIOL; ETONOGESTREL

Hepatic enzyme inducers may decrease efficacy and increase breakthrough bleeding Must be removed if a patient becomes pregnant.

ETHINYL ESTRADIOL; LEVONORGESTREL

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ETHMOZINE

Comprehensive clinical and safety monograph for ETHMOZINE (ETHMOZINE).

ETHOSUXIMIDE

CNS depressants may enhance sedative effects Can cause blood dyscrasias including aplastic anemia and SLE.

ETHRANE

Comprehensive clinical and safety monograph for ETHRANE (ETHRANE).

ETHRIL 250

Comprehensive clinical and safety monograph for ETHRIL 250 (ETHRIL 250).

ETHRIL 500

Comprehensive clinical and safety monograph for ETHRIL 500 (ETHRIL 500).

ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL

Inducers of CYP450 enzymes (eg carbamazepine) may decrease estrogen levels Increases risk of thromboembolic disorders and endometrial cancer.

ETHYOL

Comprehensive clinical and safety monograph for ETHYOL (ETHYOL).

ETICOVO

Comprehensive clinical and safety monograph for ETICOVO (ETICOVO).

ETIDRONATE DISODIUM

Comprehensive clinical and safety monograph for ETIDRONATE DISODIUM (ETIDRONATE DISODIUM).